Corporate Scholarship Programmes (Training Outside Hong Kong) on Professional Development for Pharmacists

Loqtorzi ( Toripalimab) for nasopharyngeal carcinoma

Medication Safety in Paediatric Patients

Hong Kong College of Health Service Executives (HKCHSE) - Annual Conference 2025 cum 20th Anniversary Celebration

Handling of Dangerous Drugs in HA Pharmacies

Communication Skills with Psychiatric Patients

Imdelltra ( Tarlatamab ) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

CAHMR Health Services Management Seminar Series 10: Environment and Healthy City

Evrenzo ( Roxadustat ): New solutions to chronic kidney disease (CKD) anaemia management

Nefecon ( Budesonide ): a targeted-release formulation for Primary IgA Nephropathy (IgAN)

Capacity Building Workshop 2025 - Insomnia Management in Primary Care

Sacituzumab govitecan for first-line and beyond in mTNBC

CAHMR Health Services Management Seminar Series 9: Governance in ESG in Hong Kong

Healthcare Service Management Training (HSMT) CS003 - Management of HA Drug Formulary

Breast Cancer Symposium in Hong Kong - Emerging Approaches in ER+ HER2- Metastatic Breast Cancer Management

Orkedia ( Evocalcet ): An Introduction

PEDSAP 2025

Hong Kong Primary Care Conference 2025

Nutritional Products and Strategies for Weight Management

Retsevmo ( Selpercatinib ) for the treatment of advanced RET fusion-positive Non-Small Cell Lung Cancer (NSCLC)

Type 1 Diabetes prediction, prevention and classification across the globe

Implementing precision diabetes care

Ribociclib (brand: Kisqali) for adjuvant therapy of early breast cancer

探索香港未來: 重大疾病醫保研討會 2025

Lumirix ( Ruxolitinib ) cream: An introduction

International Digestive Disease Forum 2025

Best of ASCO 2025, HONG KONG

CPCE Health Conference 2025 - Primary Healthcare Policy Development in the Asia-Pacific Region

Participation as preceptors/tutors in the pharmacy internship training programme 2025/26 *New

Pharmaceutical Care in Geriatrics: ASEAN's Response to an Aging Population